Bromelain-based chemo-herbal combination effect on human cancer cells: in-vitro study on AGS and MCF7 proliferation and apoptosis

1. DeSantis CE, Lin LC, Mariotto AB, Siegel RL, Stein KD, Kramer JL, et al. Cancer treatment and survivorship statistics, 2014. CA Cancer J Clin. 2014;64(4):252-71.10.3322/caac.2123524890451Search in Google Scholar

2. Raeisi E, Aghamiri SM, Bandi A, Rahmatpour N, Firoozabadi SM, Kafi-Abad SA, et al. The antitumor efficiency of combined electrochemotherapy and single dose irradiation on a breast cancer tumor model. Radiol Oncol. 2012;46(3):226-32.10.2478/v10019-012-0035-x347294723077461Search in Google Scholar

3. Pérez-Herrero E, Fernández-Medarde A. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy. Eur J Pharm Biopharm. 2015;93:52-79.10.1016/j.ejpb.2015.03.01825813885Search in Google Scholar

4. Ghosh S. Cisplatin: The first metal based anticancer drug. Bioorg Chem. 2019;88:102925.10.1016/j.bioorg.2019.10292531003078Search in Google Scholar

5. Damia G, Broggini M. Platinum resistance in ovarian cancer: Role of DNA repair. Cancers (Basel). 2019;11(1):119.10.3390/cancers11010119635712730669514Search in Google Scholar

6. Maehara Y, Oki E, Saeki H, Tokunaga E, Kitao H, Iimori M, et al. Evolving 5-fluorouracil therapy to achieve enhanced efficacy-past and current efforts of researchers. Gan To Kagaku Ryoho. 2016; 43(7):845-54.Search in Google Scholar

7. Sun W, Sanderson P, Zheng W. Drug combination therapy increases successful drug repositioning. Drug Discov Today. 2016;21(7): 1189-95.10.1016/j.drudis.2016.05.015490786627240777Search in Google Scholar

8. Rathnavelu V, Alitheen N, Sohila S, Kanagesan S, Ramesh R. Potential role of bromelain in clinical and therapeutic applications. Biomed Rep. 2016;5(3):283-8.10.3892/br.2016.720499815627602208Search in Google Scholar

9. Satari A, Amini AS, Raeisi E, Lemoigne Y, Hiedarian E. Synergetic impact of combined 5-fluorouracil and rutin on apoptosis in pc3 cancer cells through the modulation of p53 gene expression. Adv Pharm Bull. 2019;9(3):462-9.10.15171/apb.2019.055677393931592435Search in Google Scholar

10. Pauzi AZ, Yeap S, Abu N, Lim KL, Omar AR, Aziz SA, et al. Combination of cisplatin and bromelain exerts synergistic cytotoxic effects against breast cancer cell line MDA-MB-231 in vitro. Chin Med. 2016;11:46.10.1186/s13020-016-0118-5511126427891174Search in Google Scholar

11. Raeisi F, Shahbazi-Gahrouei D, Raeisi E, Heidarian E. Evaluation of the radiosensitizing potency of bromelain for radiation therapy of 4t1 breast cancer cells. J Med Signals Sens. 2019;9(1):68-74.10.4103/jmss.JMSS_25_18641956430967992Search in Google Scholar

12. Amini A, Masoumi-Moghaddam S, Ehteda A, Morris DL. Bromelain and n-acetylcysteine inhibit proliferation and survival of gastrointestinal cancer cells in vitro: Significance of combination therapy. J Exp Clin Cancer Res. 2014;33(1):92.Search in Google Scholar

13. Amini A, Masoumi-Moghaddam S, Ehteda A, Liauw W, Morris DL. Potentiation of chemotherapeutics by bromelain and n-acetylcysteine: Sequential and combination therapy of gastrointestinal cancer cells. Am J Cancer Res. 2016;6(2):350-69.Search in Google Scholar

14. Müller A, Barat S, Chen X, Bui KC, Bozko P, Malek NP, et al. Comparative study of antitumor effects of bromelain and papain in human cholangiocarcinoma cell lines. Int J Oncol. 2016;48(5): 2025-34.10.3892/ijo.2016.341126935541Search in Google Scholar

15. Pillai K, Ehteda A, Akhter J, Chua TC, Morris DL. Anticancer effect of bromelain with and without cisplatin or 5-fu on malignant peritoneal mesothelioma cells. Anticancer Drugs. 2014;25(2):150-60.10.1097/CAD.000000000000003924366282Search in Google Scholar